The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.
From: www.news-medical.net
FDA approves INVEGA treatment for schizophrenia
Posted by Ruslan Abuzant at 7:02 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment